# Zilucoplan® in Improving Oxygenation, Short-, Longterm Outcome of COVID19 Patients With Acute Hypoxic Respiratory Failure

> **NCT04382755** · PHASE2 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 81 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Zilucoplan®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04382755
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-22
- **Primary completion:** 2020-12-29
- **Final completion:** 2021-04-09
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2023-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04382755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04382755, "Zilucoplan® in Improving Oxygenation, Short-, Longterm Outcome of COVID19 Patients With Acute Hypoxic Respiratory Failure". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04382755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*